Provided by Tiger Trade Technology Pte. Ltd.

SHANDONG XINHUA

5.815
+0.1101.93%
Volume:1.10M
Turnover:6.43M
Market Cap:4.05B
PE:11.85
High:5.890
Open:5.675
Low:5.660
Close:5.705
52wk High:7.418
52wk Low:5.029
Shares:697.00M
HK Float Shares:195.00M
Volume Ratio:0.82
T/O Rate:0.57%
Dividend:0.18
Dividend Rate:3.01%
EPS(LYR):0.491
ROE:4.10%
ROA:1.89%
PB:0.66
PE(LYR):11.85
PS:0.41

Loading ...

Shandong Xinhua Pharmaceutical Receives Drug Registration Certificate for Sevelamer Carbonate Dry Suspension

Stock News
·
Jun 01

AH Share Premium and Deviation Rankings as of May 29 Close

Stock News
·
May 29

AH Premium and Deviation Rankings as of May 27th

Stock News
·
May 27

Shandong Xinhua: Shareholders Asked to Confirm Attendance for 2025 AGM on 26 June 2026

Bulletin Express
·
May 26

Shandong Xinhua Pharmaceutical Unveils AGM Agenda, Share Capital Update and Auditor Re-appointment

Bulletin Express
·
May 26

AH Premium and Deviation Rankings as of May 25th

Stock News
·
May 25

Xinhua Pharma's Anxiety Drug Passes Chinese Regulator's Quality Consistency Evaluation; Secures Approval

MT Newswires Live
·
May 18

SHANDONG XINHUA Announces Successful Generic Drug Consistency Evaluation for Phenobarbital Tablets

Stock News
·
May 18

Xinhua Pharma Secures Registration Certificate for Respiratory Oral Solution in China

MT Newswires Live
·
May 11

Xinhua Pharmaceutical obtains NMPA approval for Ambroxol-Clenbuterol oral solution

Bulletin Express
·
May 11

SHANDONG XINHUA (00719) Secures Drug Registration Certificate for Ambroxol and Clenbuterol Oral Solution

Stock News
·
May 11

Shandong Xinhua Pharmaceutical Shares Surge Over 7% After Approval for Self-Developed Benserazide Hydrochloride API

Stock News
·
May 11

Xinhua Pharmaceutical Gets China Nod to Market Parkinson's Drug

MT Newswires Live
·
May 08

SHANDONG XINHUA Receives Approval Notice for Benserazide Hydrochloride API

Stock News
·
May 08

China Oil and Gas swaps assets with Shengli for RMB 1.75 billion stake boost

Reuters
·
Apr 30

Xinhua Pharmaceutical's Q1 Profit Slides 25%

MT Newswires Live
·
Apr 28

山新华制药2025年营收微增、净利下滑,经营现金流显著改善

Bulletin Express
·
Apr 28

SHANDONG XINHUA Reports Q1 Net Profit of 83.9 Million Yuan, Down 25.15% Year-on-Year

Stock News
·
Apr 28

Xinhua Pharmaceutical Publishes 2025 ESG Report: Carbon-Peak Target Set for 2030, R&D Outlays Reach RMB 379.73 Million

Bulletin Express
·
Apr 28

Shandong Xinhua Initiates Full Electronic Distribution of Corporate Communications, Seeks Shareholders’ Email Details

Bulletin Express
·
Apr 28